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Background
During the final stages of differentiation of mammalian erythroid cells, the chromatin is con-
densed and enucleated. We previously reported that Rac GTPases and their downstream target,
mammalian homolog of Drosophila diaphanous 2 (mDia2), are required for enucleation of in
vitro cultured mouse fetal liver erythroblasts. However, it is not clear how chromatin conden-
sation is achieved and whether it is required for enucleation.  
Design and Methods
Mouse fetal liver erythroblasts were purified from embryonic day 14.5 pregnant mice and cul-
tured in erythropoietin-containing medium. Enucleation was determined by flow-cytometry
based analysis after treatment with histone deacetylase inhibitors or infection with lentiviral
short harirpin RNA.  
Results
We showed that histone deacetylases play critical roles in chromatin condensation and enucle-
ation in cultured mouse fetal liver erythroblasts. Enzymatic inhibition of histone deacetylases
by trichostatin A or valproic acid prior to the start of enucleation blocked chromatin condensa-
tion, contractile actin ring formation and enucleation. We further demonstrated that histone
deacetylases 1, 2, 3 and 5 are highly expressed in mouse fetal erythroblasts. Short hairpin RNA
down-regulation of histone deacetylase 2, but not of the other histone deacetylases, phenotyp-
ically mimicked the effect of trichostatin A or valproic acid treatment, causing significant inhi-
bition of chromatin condensation and enucleation. Importantly, knock-down of histone
deacetylase 2 did not affect erythroblast proliferation, differentiation, or apoptosis.  
Conclusions
These results identify histone deacetylase 2 as an important regulator, mediating chromatin
condensation and enucleation in the final stages of mammalian erythropoiesis.  
Key words: histone deacetylase 2, HDAC2, chromatic condensation, enucleation, mammalian
erythropoiesis.
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Introduction
Mammalian erythropoiesis from the colony-forming
unit - erythroid (CFU-E) progenitor cell involves sequential
erythropoietin-dependent and -independent stages.1 In the
early stages erythropoietin prevents CFU-E cell apoptosis;
it supports rapid cell divisions and induction of hundreds
of genes encoding erythrocyte-important proteins. The
latter stages are erythropoietin-independent and involve
chromatin condensation, cell cycle arrest, and enucleation.
Whereas in all vertebrates the erythrocyte nucleus
becomes highly condensed, enucleation is unique to mam-
malian erythrocytes. The extruded nucleus is surrounded
by a plasma membrane that shows a distinct surface pro-
tein expression profile with low levels of glycophorin A
and transferrin receptor compared to the incipient reticu-
locyte; little cytoplasm remains in the extruded nucleus.2
The membrane enveloping the nucleus also contains high
levels of phosphatidylserine, which serves as a signal for
engulfment by macrophages.3 Although our understand-
ing of mammalian erythroid cell enucleation has increased
since morphological studies decades ago,4,5 most of the
molecular mechanisms remain unknown. Recent studies
suggest that non-apoptotic activities of caspases6,7 and of
the tumor suppressor protein Rb8,9 play important roles in
erythroid enucleation. In addition, several studies suggest
that enucleation requires that the erythroid cells interact
with extracellular matrix proteins,10 macrophages,11,12 or
sinusoidal endothelium.13 These observations, however,
are limited and there is little evidence demonstrating that
any single regulatory pathway plays a primary role in the
enucleation process.
Using an in vitro cultured mouse fetal liver erythroblast
system,14 we previously demonstrated that deregulation of
Rac GTPases during the late stages of erythropoiesis com-
pletely blocked enucleation of cultured mouse fetal ery-
throblasts without affecting normal proliferation or differ-
entiation. A contractile actin ring normally forms on the
plasma membrane of late-stage erythroblasts at the
boundary between the cytoplasm and nucleus of enucleat-
ing cells; formation of this cytoskeletal structure was dis-
rupted when Rac GTPase was inhibited in late stages of
erythropoiesis. Rac GTPase activity is mediated by the
downstream target protein, mammalian homolog of
Drosophila diaphanous 2 (mDia2), a formin required for
nucleation of unbranched actin filaments.2 These results
revealed important roles for the Rac GTPase and mDia2 in
enucleation of mammalian erythroblasts.15
Chromatin condensation during the late stages of ery-
thropoiesis involves many histone modifications such as
deacetylation, presumably catalyzed by histone deacety-
lases (HDAC). There are 18 known HDAC. HDAC1, 2, 3
and 8 belong to class I; these HDAC are homologous to
the yeast RPD3 protein and reside in the nucleus. HDAC4,
5, 7 and 9 belong to class IIa and they shuttle between the
nucleus and the cytoplasm. HDAC6 and HDAC10 are
class IIb HDAC that contain two catalytic HD domains.
All of these HDAC contain a zinc catalytic domain that is
inhibited by trichostatin A.16 HDAC play essential roles in
chromatin remodeling, epigenetic regulation, and gene
expression, processes that are critical for normal cell differ-
entiation and proliferation.17-19 HDAC also play important
roles in determining the fate of hematopoietic cells. In red
cells, HDAC negatively regulate the interleukin-3-
mediated growth of early erythroid precursors by sup-
pressing their responsiveness to interleukin-3, and play an
important role in erythropoietin-mediated differentiation
and survival of erythroid precursors.20
HDAC also play critical roles in terminal erythropoiesis.
Popova et al. recently demonstrated that the activities of
HDAC are required for chromatin condensation in Friend-
virus infected murine spleen erythroblasts (FVA cells).21 In
this study, HDAC5 expression was shown to be increased
during terminal erythropoiesis. However, a role for
HDAC5 in mammalian erythroblast chromatin condensa-
tion and enucleation needs to be re-examined as no loss of
function studies have been done. The use of FVA cells also
raises concerns, as retrovirus infection often introduces
genetic and epigenetic modifications. 
Here we used an in vitromouse fetal erythroblast culture
system to investigate the role of HDAC in chromatin con-
densation and subsequent enucleation of primary mouse
erythroblasts. 
Design and Methods
Materials
Mouse monoclonal antibodies against HDAC1, HDAC2,
HDAC3 and H4K16ac were purchased from Abcam. The poly-
clonal antibody against HDAC5 was purchased from Cell
Signaling Technology. The monoclonal antibody against mDia2
was purchased from Santa Cruz Biotechnology. All antibodies for
flow cytometric analysis were purchased from BD Biosciences.
Alexa Fluor 488 phalloidin for contractile actin ring staining was
purchased from Invitrogen Molecular Probes.  
Purification and culture of fetal liver cells
Purification and in vitro culture of mouse fetal liver erythroblast
precursors (CFU-E; TER119-negative cells) were modified based
on the procedures previously described.14 In brief, fetal liver cells
were isolated from E13.5 C57BL/6 embryos and mechanically dis-
sociated by pipetting in phosphate-buffered saline containing 10%
fetal bovine serum (GIBCO). Single-cell suspensions were pre-
pared by passing the dissociated cells through 70 mm and 25 mm
cell strainers. Total fetal liver cells were labeled with biotin-conju-
gated anti-TER119 antibody (1:100) (BD Pharmingen), and
TER119-negative cells were purified through a StemSep column
according to the manufacturer’s instructions (Stem Cell
Technologies). Purified cells were seeded in fibronectin-coated
wells (BD Pharmingen) at a cell density of 1¥105/mL. The purified
cells were cultured in Iscove’s modified Dulbecco’s medium con-
taining 15% fetal bovine serum (StemCell Technologies), 1%
detoxified bovine serum albumin, 200 mg/mL holo-transferrin
(Sigma), 10 mg/mL recombinant human insulin (Sigma), 2 mM L-
glutamine, 10-4 M β-mercaptoethanol, and 2 U/mL erythropoietin
(Amgen).  
Generation of lentivirus and infection of fetal
liver erythroblasts
The hairpin-pLKO.1 bacterial glycerol stocks were purchased
from the Broad Institute  (Cambridge, MA, USA). A mixture of five
lentiviral vectors encoding different short hairpin RNA (shRNA)
sequences was employed for each HDAC. The sequences of the
shRNA are given in the Online Supplementary Design and Methods.
Lentivirus production from 293T cells was performed as instructed
(http://www.broadinstitute.org/genome_bio/trc/publicProtocols.html). For
infection of the purified TER119-negative fetal liver cells, 1¥105
cells were resuspended in 1 mL thawed viral supernatant contain-
ing 10 mg/mL polybrene (Sigma) and centrifuged at 2000 rpm for 1
P. Ji et al.
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h at 37°C. The cells were then changed to differentiation medium
as above for 2 days. 
Flow cytometric analysis
Flow cytometric analysis of the differentiation status of cultured
mouse fetal erythroblasts was described previously.2 Briefly, fetal
liver cells were immunostained with phycoerythrin-conjugated
anti-TER119  (1:200)  (BD Pharmingen) and fluorescein isothio-
cyanate-conjugated anti-CD71  (1:200)  (BD Pharmingen) antibod-
ies, for 15 min at room temperature. Propidium iodide was added
to exclude dead cells from analysis. For enucleation analyses, cells
were stained with 10 mg/mL Hoechst 33342, in addition to other
fluorophore-conjugated antibodies, for 15 min at room tempera-
ture.
Confocal microscopy and estimation of nuclear volume
Images of erythroblast nuclei were collected at vertical intervals
of 0.75 mm using a LSM 510 Meta confocal microscope system
(100M, NA 1.4 Plan-Apochromat lens). Stacks of images were
then processed using the isosurface module of Imaris 6.4 (Bitplane,
Scientific Solutions) to obtain the estimated nuclear volume. We
defined the mean estimated nuclear volume of control cells as
100%. Statistical analysis was performed with Graph Pad Prism
software, using the unpaired t-test with a confidence interval of
95%.
Cell cycle analysis
Cultured mouse fetal erythroid cells (2¥106) were harvested and
resuspended in 200 mL phosphate-buffered saline containing 2%
fetal bovine serum (GIBCO). To permeablize the cells, we added
5 mL 95% ethanol drop-wise while vortexing the cells at low
speed. The cells were stored at 4°C for 1 h or overnight. The cells
were then washed once with phosphate-buffered saline (2% fetal
bovine serum) and resuspended in 1 mL propidium iodide staining
solution that contains 50 mg/mL propidium iodide, 10 mM Tris pH
7.5, 5 mM MgCl2, and 10 mg/mL RNase. After incubation for 30
min at 37°C, the cells were subjected to flow cytometry for cell
cycle profile analysis. 
Contractile actin ring staining
Contractile actin ring staining was performed as described pre-
viously.2 Essentially, cultured mouse fetal erythroid cells were har-
vested and resuspended in phosphate-buffered saline containing
10 mM glucose and 1 mg/mL bovine serum albumin (resuspension
buffer). Cells were pelleted at 900g for 5 min and then fixed in 100
mL 0.5% acrolein phosphate-buffered saline for 5 min in solution.
Resuspension buffer was then added to adjust cells to approxi-
mately 5¥106 cells/mL. Cells (100 mL) were applied to poly-l-
lysine-coated slides (Electron Microscopic Science) and allowed to
sit for 40 min at room temperature. The slides were rinsed three
times in phosphate-buffered saline containing 0.1 M glycine  (rins-
ing buffer) to remove unbound cells. Cells were permeabilized in
rinsing buffer containing 0.05% Triton X-100 for 15 s, followed by
three washes in the same buffer without detergent. Cells were
then incubated in rinsing buffer for an additional 30 min followed
by incubation in blocking buffer (phosphate-buffered saline con-
taining 0.5 mM glycine, 0.2% fish skin gelatin and 0.05% sodium
azide) for 1 h. These cells were then incubated with 1 U/mL Alexa
Fluor 488–phalloidin in blocking buffer for 1 h. Cells were then
washed three times in blocking buffer followed by 4',6-diamidino-
2-phenylindole (DAPI) staining for 5 min. Images were taken with
a Nikon inverted TE300 epi-fluorescence microscope. 
Hemoglobin quantification 
Mouse fetal liver TER119-negative cells were purified, infected
and cultured for 2 days as described above. Hemoglobin was
quantified by lysing 1¥106 cells in 200 mL Drabkin’s reagent
according to the manufacturer’s instructions (Sigma Aldrich).
Spectrophotometric reading was then performed at 540 nm. 
Statistical analysis
Statistical analysis was performed using GraphPad Prism soft-
ware. Student’s t-test was used to determine the significance of
differences between results from experimental groups compared
to those from control ones.  
Results 
Inhibition of the activities of histone deacetylases 
at the late stages of mouse fetal erythropoiesis 
blocks enucleation but not normal differentiation 
or proliferation 
Our previous study demonstrated that the nuclei of cul-
tured mouse fetal erythroblasts undergo gradual conden-
sation before enucleation.2 In the light of the significant
roles of HDAC in chromatin remodeling, we tested
whether pharmacological inhibition of these enzymes
blocked enucleation of primary mouse erythroblasts. To
this end, we purified TER119- (an antigen associated with
erythroid cell-surface glycophorin A22) negative erythroid
progenitor cells from E13.5 mouse fetal livers and cultured
them for 2 days in fibronectin-coated plates with erythro-
poietin; these erythroblasts mimic erythroid cell develop-
ment in vivo in that they undergo four to five terminal cell
divisions, up-regulate hemoglobins and erythroid cell-spe-
cific membrane proteins, and undergo chromatin conden-
sation followed by enucleation.14 On day 2, roughly 30%
of cells had enucleated.2 We treated the cells with trico-
statin A  (TSA), a pan-HDAC inhibitor, or valproic acid
(VPA), a class I-specific HDAC inhibitor,23,24 at 30 h of cul-
ture, roughly the starting time of enucleation.2 Figure 1A
shows that treatment of erythroblasts with 10 nM TSA or
1 mM VPA dramatically blocked enucleation at 48 h; the
percentage of TER119highHoechstlow cells (incipient reticulo-
cytes) was dramatically decreased compared to the per-
centage of incipient reticulocytes among dimethylsulfox-
ide-treated control cells. Importantly, TSA or VPA treat-
ment did not block normal differentiation of erythroblasts
since the cells exhibited full induction of TER119 by 48 h
in culture (Figure 1A lower panels). The percentage of the
TER119-positive population appeared to be increased in
TSA- or VPA-treated cells, but this is due to the fact that
Ter119 staining of the extruded nuclei in the control cell
population (CD71medTER119low cells)2 (Online Supplementary
Figure S1) was decreased. In addition, benzidine-Giemsa
staining of the same cells from Figure 1A showed that
TSA- or VPA-treated cells contained similar hemoglobin
levels (orange benzidine-positive cells) as control cells,
which demonstrates again that TSA or VPA treatment
does not block normal mouse fetal liver erythroid differen-
tiation (Figure 1B). These results were further confirmed
by the studies illustrated in Figure 1C, showing that the
concentration of the hemoglobin levels in TSA- or VPA-
treated cells was the same as in control cells. 
There was also no difference in apoptosis between
treated and control cells (data not shown). We further tested
whether treatment of the cultured mouse fetal liver ery-
throblasts with TSA or VPA blocked cell proliferation.
HDAC2 in mammalian erythropoiesis
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Indeed, the total number of cells at 48 h decreased when
the cells were treated with TSA or VPA at 30 h in culture
(Figure 1D). But since enucleation forms one nucleus and
one reticulocyte, as we described before, we took this fac-
tor into account2 and found that there was no significant
decrease in cell number when cells were treated with TSA
or VPA at 30 h of culture (Figure 1D). 
We also performed cell cycle analysis on these cells. To
this end, cell cycle profiles at different time points during
the in vitro culture of TER119-negative erythroblasts were
first obtained. Online Supplementary Figure S2 shows that a
significant number of the cultured TER119-negative cells
were in S phase during the first 30 h in culture. The cells
quickly became arrested at G1 phase after 30 h. We com-
pared the cell cycle profile of TSA- or VPA-treated cells
with that of the control ones at 40 h in culture and found
no detectable difference (Figure 1E). Taken together, these
results demonstrate that the activities of HDAC are
required for enucleation, but not for terminal differentia-
tion or proliferation of primary mouse fetal erythroblasts.
Histone deacetylases regulate chromatin condensation
and contractile actin ring formation during the late
stages of mouse fetal erythropoiesis
To test directly whether inhibition of the activities of
HDAC block chromatin condensation in terminal erythro-
poiesis, we treated the cultured fetal liver erythroblasts
with 10 nM or 20 nM of TSA at 30 h in culture. We fixed
the cells at 42 h and stained them with Hoechst to detect
nuclei. Figure 2A demonstrates that TSA-treated erythroid
cells exhibited significantly enlarged nuclei compared to
control cells. VPA treatment had similar effects (data not
shown). The size of the nucleus was quantified using Z-
stacks, and Figure 2B shows that the estimated nuclear
volume of TSA or VPA-treated cells was significantly larg-
er than that of control cells. 
We also analyzed the formation of the contractile actin
ring during the enucleation process2 in the presence and
absence of TSA or VPA. Figure 2C shows that TSA-treated
erythroblasts exhibited irregular actin distribution com-
pared to the normal bright green dots characteristic of the
contractile actin ring. VPA-treated cells showed similar
changes (data not shown). These results confirm our
hypothesis that chromatin condensation, regulated by
HDAC, is required for enucleation. The blockage of con-
tractile actin ring formation also suggests that this activity
of the HDAC may occur before activation of the
RacGTPase-mDia2 pathway and formation of the con-
tractile actin ring.2
Histone deacetylases 1, 2, 3 and 5 are highly
expressed in mouse fetal erythroblasts
To determine the expression levels of different HDAC
during erythropoiesis, we performed real-time poly-
P. Ji et al.
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Figure 1. Histone deacetylases are required for enucleation, but not terminal differentiation or proliferation, of cultured mouse fetal liver ery-
throblasts.  (A) Purified TER119-negative E13.5 mouse fetal liver erythroid progenitor cells were cultured in vitro in fibronectin-coated plates
in medium containing serum and erythropoietin (Epo). Tricostatin A 10 nM or valproic acid (VPA) 1 mM was added after 30 h in culture and
cells were harvested after 48 h. The enucleation and differentiation status of cultured cells after TSA or VPA treatment were analyzed by
flow cytometric analysis using staining with Hoechst 33342 and TER119–PE, and FITC–CD71 and TER119–PE, respectively. The percentages
of enucleated incipient reticulocytes (top panels) and TER119-positive cells  (bottom panels) are illustrated. (B) The same cells as in A were
stained with benzidine-Giemsa. The scale bar represents 7 mm. (C) Hemoglobin concentrations of indicated cells analyzed at 48 h in culture.
(D) The same cells as in A were counted at 0, 30 and 48 h in culture and the total number is shown. The total number of cells at 48 h was
normalized, calculated as the number of nucleated erythroblasts plus one half of the total numbers of reticulocytes and nuclei. (E) Cell cycle
analysis of the indicated cells at 40 h in culture. The percentages of the cells at G1, S, and G2 phases are shown. 
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merase chain reaction analyses of cultured fetal liver ery-
throblasts harvested at 0, 24, and 48 h in culture. Figure 3A
shows that the mRNA expression levels of HDAC1,
HDAC2, HDAC3, and HDAC5 are higher than those of
other HDAC in erythroid cells. Rac1 was used as a posi-
tive control as we have demonstrated that it is highly
expressed in erythroid cells.2 It is notable that the mRNA
expression level of each HDAC is decreased during termi-
nal proliferation and differentiation of mouse fetal ery-
throblasts. Consistent with their gradually decreased
mRNA levels during erythropoiesis, the protein levels of
HDAC1 and HDAC3 also decreased during the 48 h cul-
ture (Figure 3B). In contrast, the protein levels of HDAC2
and HDAC5 increased and reached a maximal level at 48
h in culture. We also found that acetylation of histone H4-
K16 (H4K16ac), which controls the global chromatin
structure and protein interactions,25 is gradually decreased
during erythropoiesis (Figure 3B).
Histone deacetylase 2, but not histone deacetylase 1,
3, or 5, is required for chromatin condensation, 
contractile actin ring formation and enucleation
To directly test whether any HDAC is required for ery-
throid cell chromatin condensation and enucleation, we
infected isolated TER119-negative mouse fetal erythroid
progenitor cells before culture with lentiviruses encoding
shRNA targeting mRNA encoding HDAC1, 2, 3 or 5. Cells
were harvested at 48 h of culture for western blot analysis
to detect the knockdown level of each individual HDAC,
and flow cytometry analysis was performed to detect enu-
cleation. A maximum decrease of the corresponding
mRNA levels was achieved after approximately 30 h in
culture2 and levels of each mRNA were decreased by more
than 80%. Figure 4A illustrates the decreased protein
expression levels of HDAC1, 2, 3 and 5 with lentiviral
shRNA infection. Significantly, analysis at 48 h in culture
showed that only down-regulation of HDAC2 dramatical-
ly inhibited erythroblast enucleation, whereas HDAC1,
HDAC3 or HDAC5 down-regulation had no effects
(Figure 4B and 4C). As we expected, the level of acetylated
H4K16 was increased when HDAC2 was down-regulated
(Figure 4D).
Similar to TSA or VPA treatment, knockdown of
HDAC2 also significantly blocked nuclear condensation
(Figure 5A). Alexa Fluor 488-phalloidin staining of the
HDAC2 shRNA-infected cells after 48 h in culture demon-
strated defects in contractile actin ring formation com-
pared to that of the control shRNA-infected cells (Figure
5B and 5C). Cells in which HDAC5 was knocked down
showed no defects in these processes (data not shown). 
HDAC2 in mammalian erythropoiesis
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Figure 2. Histone deacetylases are
required for chromatin condensation
of cultured mouse fetal liver ery-
throblasts.  (A) Confocal microscopy
analysis of TSA-treated mouse fetal
liver erythroblasts. TER119-negative
mouse fetal liver erythroblasts were
cultured as in Figure 1.  After 30 h,
the indicated amount of TSA was
added. Cells were harvested after 42
h and analyzed by confocal
microscopy. Z-projections of DNA
(blue) are shown. The scale bar rep-
resents 5 mm  (B) Quantification of
the estimated nuclear volume of the
cells shown in A and VPA-treated
cells. *P<0.001, **P<0.0001. (C)
The same cells as in A treated with
10 nM of TSA after 30 h in culture
were harvested after 48 h and
stained with Alexa Fluor 488–phal-
loidin. The scale bar represents 8
mm. 
Figure 3. HDAC 1, 2, 3 and 5 are
highly expressed in cultured mouse
fetal liver erythroblasts. (A) The
mRNA expression levels of different
HDAC during in vitro culture of
TER119-negative mouse fetal ery-
throblasts, as quantified by quantita-
tive real-time polymerase chain reac-
tion analysis. The relative level com-
pared to 18S rRNA was calculated
using the DDCt method.  (B) Protein
expression levels of HDAC 1, 2, 3 and
5, as well as histone H4 and acetylat-
ed H4K16 during in vitro culture of
TER119-negative mouse fetal ery-
throblasts analyzed by western blot.
The mDia2 and GAPDH protein levels
are shown as positive and internal
loading controls, respectively. 
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Knockdown of histone deacetylase 2 at the late stages
of mouse fetal erythropoiesis does not affect normal
differentiation or proliferation
We next performed flow cytometric analysis of the lev-
els of cell surface expression of glycophorin A (TER119)
and the transferrin receptor (CD71). Figure 6A demon-
strates that by this criterion down-regulation of HDAC1,
HDAC2, HDAC3 or HDAC5 did not affect normal ery-
throid differentiation. It is notable that the percentage of
the TER119-positive cells in the HDAC2 knockdown
model was higher than in the others (Figure 6A and 6B).
As with TSA- and VPA-treated cells (Figure 1A), this is due
to the fact that the population of the extruded nuclei,2
which is CD71medTER119low, was decreased after HDAC2
P. Ji et al.
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Figure 4. Depletion of HDAC2 inhibits enucleation and chromatin condensation  (A) Depletion of HDAC 1, 2, 3 and 5 in primary erythroid
cells by shRNA. TER119-negative mouse fetal erythroblasts were infected with lentiviral vectors encoding shRNA specific for HDAC 1, 2, 3
or 5 and cultured for 48 h. Lysates were subjected to western blotting for individual proteins as indicated. Controls show GAPDH levels. The
gels were scanned and quantified. Controls were set as 100. (B) Flow cytometric analysis of cells infected with lentirviruses encoding HDAC
1, 2, 3 or 5 shRNA and cultured for 2 days, as in Figure 1. Cells were stained with TER119–PE and Hoechst 33342 and analyzed by FACS.
The percentages of incipient reticulocytes are indicated.  (C) Quantification of incipient reticulocytes in cells infected with indicated lentivirus-
es.  (D) Western blot analysis of acetylated H4K16 when HDAC2 was down-regulated by shRNA.
Figure 5. Depletion of HDAC2 blocks chromatin condensation and contractive actin ring (CAR) formation of cultured mouse fetal liver ery-
throblasts.  (A) Quantification of the estimated nuclear volume of 2-day cultured mouse fetal liver erythroblasts infected with lentiviruses
expressing HDAC2 shRNA.  (B) Alexa Fluor 488–phalloidin staining the same cells as in A. The scale bar represents 5 mm.  (C). Quantification
from B of cells containing a CAR. Three independent experiments were performed with roughly 200 cells counted in randomly picked areas.
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knockdown.  Again, as for TSA and VPA treatment,
knockdown of HDAC2 did not affect the degree of benzi-
dine staining compared with that of cells treated with con-
trol shRNA (Figure 6C). As further confirmation that
down-regulation of HDAC2 only affects chromatin con-
densation and enucleation, Figure 6D shows that there
was no detectable difference in the concentration of adult
hemoglobin levels between HDAC2 shRNA-infected cells
and control shRNA-infected cells. Also similar to TSA and
VPA treated cells, down-regulation of HDAC2 had no sig-
nificant effect on cell proliferation (Figure 6E). In addition,
and as we expected, HDAC2 knockdown did not affect
cell cycle profiles compared to control shRNA-infected
cells (data not shown).  
Discussion
In this study we demonstrated that HDAC2, but not
other HDAC, is required for terminal erythroblast chro-
matin condensation and subsequent enucleation. We
hypothesize that significant chromatin condensation must
precede enucleation and may well signal activation of this
complex cellular process. 
We showed that treatment of mouse fetal liver ery-
throblasts with HDAC inhibitors late in terminal erythro-
poiesis inhibits chromatin condensation and completely
blocks enucleation, but does not affect cell proliferation or
erythroid differentiation. A similar result was obtained by
knocking down HDAC2 in early erythroblasts. It is widely
known that acetylation of lysine residues on histone tails,
which reduces the net protein positive charge, allows
localized chromatin expansion and facilitates gene expres-
sion. On the other hand, deacetylation of histone tails by
HDAC induces chromatin condensation and repression of
gene expression. Since terminal erythropoiesis involves
large-scale transcriptional repression, histone modifica-
tions, and chromatin condensation, a role for HDAC in
chromatin and nuclear condensation is not surprising. 
We do not know how HDAC-induced chromatin con-
densation promotes enucleation. Hypothetically, HDAC
may directly activate the Rac GTPases-mDia2 pathway to
induce enucleation. Alternatively, condensed nuclei may
activate the Rac GTPases-mDia2 pathway through
unknown factors. For instance, prior to enucleation the
membrane of the condensed nucleus becomes closely
apposed to a segment of the plasma membrane, effective-
ly squeezing out the cytosol from this segment. How this
HDAC2 in mammalian erythropoiesis
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Figure 6. Depletion of HDAC2 does not block terminal differentiation and proliferation of cultured mouse fetal liver erythroblasts.  (A) Flow
cytometric analysis of cells infected with lentivirus encoding HDAC1, HDAC2, HDAC3 or HDAC5 shRNA and cultured for 2 days, as in Figure
4B. Cells were stained with TER119–PE and FITC-CD71 and analyzed by FACS. The percentages of TER119-positive cells are quantified. (B)
Quantification of TER119-positive cells from A. (C) Benzidine-Giemsa staining of cells 48 h after infection with lentivirus encoding control or
HDAC2 shRNA. The scale bar represents 8 mm. (D) Hemoglobin concentration of cells 48 h after infection with lentivirus encoding control or
HDAC2 shRNA.  (C) The same cells as in A were counted after 48 h in culture. The total number and the normalized number, as in Figure
1D, are shown.
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happens is not known but it could require nuclear conden-
sation below a specific value. Indeed, our data show that
inhibition of HDAC activities or knockdown of HDAC2
blocks contractile actin ring formation, a prerequisite for
enucleation. 
We emphasize that proteins that are required for termi-
nal erythropoiesis may also play important roles in the
early stages of erythropoiesis. For example, we previously
demonstrated that Rac GTPases regulate mouse fetal ery-
throblast enucleation through mDia2.2 But Rac GTPases
have recently been shown to be necessary also for early
stages of erythropoiesis in bone marrow.26 Like Rac
GTPases, HDAC may also play a role in the early stages of
erythropoiesis. Indeed, Fujieda et al. demonstrated that
treatment of human erythroid cells with an HDAC
inhibitor blocks their differentiation.27 Our unpublished
results also indicate that TSA treatment of mouse fetal
erythroblasts at early time points in culture does block
normal differentiation, but we have not attempted to elu-
cidate the possible roles of any HDAC at early stages of
erythropoiesis. 
Our study identified HDAC2 as the critical regulator in
mediating chromatin condensation and enucleation dur-
ing terminal mouse fetal liver erythropoiesis.
Physiologically, HDAC2 also plays important roles in car-
diovascular and neuronal systems. HDAC2 null mice
have reduced body size and cardiovascular defects.28
Tissue-specific knock-out of HDAC2 in neurons increases
synapse number and memory facilitation.29 There were
no hematopoietic phenotypes reported in these mice,
possibly due to compensatory effects of other HDAC or
the microenvironment surrounding the erythroblast. In
this respect, our in vitro mouse fetal liver erythroblast cul-
ture system made it possible to study cell autonomous
functions of individual HDAC during erythropoiesis. In
addition, this system also allowed us to dissect the enu-
cleation process properly from earlier stages of erythro-
poiesis.   
Popova et al. recently demonstrated that enzymatic
activities of HDAC are required for chromatin condensa-
tion in Friend-virus infected murine spleen erythroblasts
(FVA cells).21 In this study, HDAC5 expression was shown
to be increased during FVA cell terminal erythroid differ-
entiation, but no loss-of-function studies were done. We
showed here that the level of HDAC5 protein increased
during the 2-day in vitro culture of mouse fetal erythrob-
lasts, consistent with findings in FVA cells. However,
shRNA knockdown of HDAC5 to over 90% at late stages
of erythropoiesis had no effect on either chromatin con-
densation or enucleation, and we can, therefore, eliminate
HDAC5 as a critical regulator of these processes. 
The fact that VPA also blocks enucleation further con-
firms the critical role of HDAC2 in the late stages of ery-
thropoiesis. VPA specifically blocks the activities of the
class I HDAC, including HDAC 1, 2, and 3. Given the fact
that we were able to achieve only partial (~80%) knock-
down of HDAC 1 and 3, we cannot rule out possible func-
tions for these HDAC in chromatin condensation and enu-
cleation. It is interesting that VPA not only blocks the
enzymatic function of HDAC2, but also selectively
induces the degradation of HDAC2 through the ubiquitin-
proteasome pathway.30 However, the protein level of
HDAC2 was not decreased after treatment with VPA at 30
h in our culture system (data not shown). It is possible that
the half-life of HDAC2 in erythroblasts is long and that
the treatment of VPA at 30 h in culture did not provide suf-
ficient time to down-regulate HDAC2. This explanation is
consistent with the fact that at 48 h in culture, although
the mRNA level of HDAC2 decreased, the HDAC2 pro-
tein level had increased considerably (Figure 3). All of
these results establish the critical role of HDAC2 in mam-
malian terminal erythropoiesis. Future studies, with a
focus on how HDAC2 mediates chromatin condensation
and provides signals to promote enucleation, will help us
to understand the detailed mechanisms of mammalian ter-
minal erythropoiesis. 
HDAC inhibitors are increasingly being developed as
anti-tumor compounds in clinical trials.31,32 These com-
pounds, including hydroxamic acids, butyrate, and cyclic
tetrapeptides, induce cancer cell apoptosis, cell cycle
arrest, and terminal differentiation.33 In addition, HDAC
inhibitors are also being used in patients with thalassemia
to improve erythropoiesis and hemoglobin production.34
Although so far no systematic clinical study has shown
that patients treated with HDAC inhibitors develop ane-
mia, attention should be paid to situations such as targeted
bone marrow drug delivery, or the administration of
HDAC isotype-specific inhibitors. 
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